Search

Your search keyword '"Hilario Nunes"' showing total 444 results

Search Constraints

Start Over You searched for: Author "Hilario Nunes" Remove constraint Author: "Hilario Nunes"
444 results on '"Hilario Nunes"'

Search Results

1. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

2. Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension

3. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trialsResearch in context

4. An adjudication algorithm for respiratory-related hospitalisation in idiopathic pulmonary fibrosis

5. Sarcoidosis-Associated Pulmonary Hypertension

6. The association between air pollution and the severity at diagnosis and progression of systemic sclerosis-associated interstitial lung disease: results from the retrospective ScleroPol study

7. Infectious Complications of Pulmonary Sarcoidosis

8. Are cleaning activities a source of exposure to crystalline silica in women with rheumatoid arthritis? A case–control study

9. Comorbidities of sarcoidosis

10. Differential diagnosis of pulmonary sarcoidosis: a review

11. Outcome following nivolumab treatment in patients with advanced non-small cell lung cancer and comorbid interstitial lung disease in a real-world setting

13. ERS International Congress 2021: highlights from the Interstitial Lung Diseases Assembly

14. No evidence for a pathogen associated with pulmonary MALT lymphoma: a metagenomics investigation

15. Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal?

16. Hypoxia Promotes a Mixed Inflammatory-Fibrotic Macrophages Phenotype in Active Sarcoidosis

17. The Affinity of Hemoglobin for Oxygen Is Not Altered During COVID-19

18. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP)

19. Environmental contamination related to SARS-CoV-2 in ICU patients

20. ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly

21. Rituximab for auto-immune alveolar proteinosis, a real life cohort study

22. G908R NOD2 variant in a family with sarcoidosis

23. Sarcoidosis-Like Cancer-Associated Granulomatosis: Characteristics and a Case-Control Comparison with Sarcoidosis

24. Research highlights from the 2018 ERS International Congress: interstitial lung diseases

25. Management of sarcoidosis in clinical practice

26. Child–Adult Transition in Sarcoidosis: A Series of 52 Patients

27. Small airways diseases, excluding asthma and COPD: an overview

28. Association Study for 26 Candidate Loci in Idiopathic Pulmonary Fibrosis Patients from Four European Populations

29. The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population.

32. French recommendations for the diagnosis and management of lymphangioleiomyomatosis

35. Germline Mutations of Telomere-Related Genes are a Major Risk Factor for Liver Disease: A Multicentric Transversal Study

36. Essential Features of an Interstitial Lung Disease Multidisciplinary Meeting An International Delphi Survey

37. Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

38. Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial

39. Drug-induced sarcoidosis-like reactions

40. Recommended Approaches to Minimize Aerosol Dispersion of SARS-CoV-2 During Noninvasive Ventilatory Support Can Cause Ventilator Performance Deterioration

41. French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version

42. Efficacy of plasma exchange in patients with anti-MDA5 rapidly progressive interstitial lung disease

43. 2022 Update of indications and contraindications for lung transplantation in France

44. Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial

45. Autoantibodies are associated with disease progression in idiopathic pulmonary fibrosis

46. Anti-PM-Scl antibodies positive patients encompass three different groups with distinct prognosis

49. Estimation of Regional Pulmonary Compliance in Idiopathic Pulmonary Fibrosis Based on Personalized Lung Poromechanical Modeling

Catalog

Books, media, physical & digital resources